Summary
Carbamazepine and its epoxide in plasma were measured by liquid chromatography in 25 patients treated with a mean dose of carbamazepine of 12.5±3.3 mg/kg body weight. The mean concentrations of parent drug and metabolite were 5.4±2.5 µg/ml and 1.10±0.42 µg/ml, respectively. A significant correlation was found between the plasma concentrations of the two compounds (r=0.64; p<0.001), but marked interindividual variation existed in the ratio of carbamazepine to epoxide. Based on simultaneous measurements in plasma and cerebrospinal fluid, the unbound fraction of carbamazepine in plasma was of the order of 20% as compared to 45% for the epoxide. Thirteen ambulant patients suffering from partial epilepsy with complex symptomatology, who were already being treated with phenytoin in optimal doses (plasma level 14–20 µg/ml) were also given carbamazepine. At plasma levels of the latter of about 5 µg/ml there was no further reduction in the frequency of partial or generalized epileptic seizures. In five patients the dose was increased to produce plasma concentrations of 7 – 8 µg/ml. There was still no improvement and side-effects were seen in three patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bird, C.A.K., Griffin, B.P., Miklascewska, J.M., Galbraith, A.W.: Tegretol (carbamazepine): A controlled trial of a new anticonvulsant. Brit. J. Psychiat.112 737–742 (1966)
Blom, S.: Tic doloreux treated with a new anticonvulsant. Arch. Neurol. (Chic.)9 285 (1963)
Bonduelle, M.: My study of Tegretol. In: Tegretol in epilepsy, Report of an International Clinical Symposium, London 1972, (ed. A.S. Wink), pp 80–88. Manchester: C. Nicholls and Co. Ltd 1972
Buchthal, F., Svensmark, O., Schiller, P.J.: Clinical and electroencephalographic correlations with serum levels of diphenyl-hydantoin. Arch. Neurol. (Chic.)2 624–630 (1960)
Cereghino, J.J., van Meter, J.C., Brock, J.T.: Preliminary observations of serum carbamazepine concentration in epileptic patients. Neurology23 357–366 (1973)
Cereghino, J.J., Brock, J.T., van Meter, J.C., Penry, J.K., Smith, L.D., White, B.G.: Carbamazepine for epilepsy. A controlled prospective evaluation. Neurology24 401–410 (1974)
Christiansen, J.: Assay of drugs and their metabolites in capillary blood. Scand. J. clin. Lab. Invest. Suppl. 118, 67 (1971)
Eichelbaum, M., Bertilsson, L.: Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatography. J. Chromatogr.103 135–140 (1975)
Eichelbaum, M., Ekbom, K., Ringberger, V.A., Bertilsson, L., Rane, A.: Plasma kinetics of carbamazepine and its epoxide metabolite in man during single and multiple dosing. Europ. J. clin. Pharmacol.8 337–341 (1975)
Frey, H., Yrjänä, T.: Carbamazepine titers in epileptic patients. Scand. J. clin. Lab. Invest. Suppl.113 90 (1970)
Frigerio, A., Fanelli, R., Biandrate, P., Passerini, G., Morselli, P.L., Garratini, S.: Mass spectrometric characterization of carbamazepine-10,11-epoxide, a carbamazepine metabolite isolated from human urine. J. pharm. Sci.61 1144–1147 (1972)
Johannesen, S., Strandjord, R.: Koncentrationen av karbamazepin i serum och cerebrospinalvätska hos 9 patienter med epilepsi. In: Plasmakoncentrationsbestämningar av antiepileptika (ed. L. Lund), pp. 25–26, Lidingö: Geigy Läkemedel 1971
Johanneson, S., Strandjord, R.E. Concentration of carbamazepine in serum and in cerebrospinal fluid in patients with epilepsy. Epilepsia14 373–379 (1973)
Kutt, H., Haynes, J., Mc Dowell, F.: Some causes of ineffectiveness of diphenyl-hydantoin. Arch. Neurol.14 489–492 (1966)
Lund, L.: Anticonvulsant effect of diphenyl-hydantoin in relative to plasma levels. Arch Neurol. (Chic.)31 289–294 (1974)
Meinardi, H.: Carbamazepine. In: Antiepileptic drugs, (eds. D.M. Woodbury, J.K. Penry, R.P. Schmidt), pp. 487–496. New York: Raven Press 1972
Möller, J.: Serumkoncentrationsbestämningar av karbamazepin inom barnneurologien, In: Plasmakoncentrationsbestämningar av antiepileptika (ed. L. Lund) pp. 72–78. Lidingö: Geigy Läkemedel 1971
Morselli, P.L., Gerna, M., Garratini, S.: Carbamazepine plasma and tissue levels in the rat. Biochem. Pharmacol.20 2043–2047 (1971)
Morselli, P.L., Biandrate, P., Frigerio, A., Gerna, M., Tognoni, G.: In: Methods of analysis of antiepileptic drugs, (eds. J.W.A. Meijer, H. Meinardi, C. Gardner Thorpe, E. van der Kleijn), p. 169. Amsterdam: Excerpta Medica 1973
Palmér, L., Bertilsson, L., Collste, P., Rawlins, M.: Quantitative determination of carbamazepine in plasma by mass fragmentography. Clin. Pharmacol. Ther.14 827–832 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eichelbaum, M., Bertilsson, L., Lund, L. et al. Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy. Eur J Clin Pharmacol 9, 417–421 (1976). https://doi.org/10.1007/BF00606558
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606558